NASDAQ:CPRX Catalyst Pharmaceuticals (CPRX) Insider Trading & Ownership $12.14 +0.01 (+0.08%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$12.11▼$12.6050-Day Range$12.10▼$15.0252-Week Range$11.09▼$22.11Volume788,539 shsAverage Volume1.87 million shsMarket Capitalization$1.29 billionP/E Ratio12.02Dividend YieldN/APrice Target$24.75 Insider TradesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$18.84 M Get CPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Catalyst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CPRX Insider Buying and Selling by Quarter Catalyst Pharmaceuticals Insider and Congressional Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails5/15/2023Patrick J McenanyCEOSell26,151$13.23$345,977.733,945,436 4/5/2023David S TierneyDirectorSell30,000$16.83$504,900.00313,541 3/29/2023Carmen Jeffrey DelInsiderSell40,000$16.70$668,000.007,541 3/28/2023Alicia GrandeCFOSell58,216$16.54$962,892.6450,557 3/22/2023Alicia GrandeCFOSell41,784$16.50$689,436.0050,557 3/20/2023Brian ElsberndInsiderSell50,000$16.07$803,500.00138,076 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/6/2022Gary IngenitoInsiderSell5,918$16.85$99,718.3030,802 11/23/2022Philip H CoelhoDirectorSell9,999$17.45$174,482.55149,553 11/23/2022Steve MillerCOOSell20,000$17.34$346,800.00553,791 11/22/2022Alicia GrandeCFOSell120,000$16.53$1,983,600.0027,442 11/21/2022Patrick J McenanyCEOSell150,000$15.33$2,299,500.003,902,606 11/21/2022Philip H CoelhoDirectorSell70,000$15.23$1,066,100.00179,553 11/21/2022Steve MillerCOOSell80,000$15.28$1,222,400.00573,791 11/18/2022Patrick J McenanyCEOSell350,000$15.62$5,467,000.003,902,606 11/15/2022Alicia GrandeCFOSell60,000$15.77$946,200.00147,442 11/11/2022Donald A DenkhausDirectorSell20,000$16.59$331,800.00277,666 11/11/2022Preethi SundaraminsiderSell56,786$16.38$930,154.68 (Data available from 1/1/2013 forward) CPRX Insider Trading Activity - Frequently Asked Questions Who is on Catalyst Pharmaceuticals's Insider Roster? The list of insiders at Catalyst Pharmaceuticals includes Alicia Grande, Brian Elsbernd, Carmen Jeffrey Del, Charles B O'keeffe, David S Tierney, Donald A Denkhaus, Gary Ingenito, Patrick J Mcenany, Philip H Coelho, Preethi Sundaram, and Steve Miller. Learn more on insiders at CPRX. What percentage of Catalyst Pharmaceuticals stock is owned by insiders? 12.10% of Catalyst Pharmaceuticals stock is owned by insiders. Learn more on CPRX's insider holdings. Which Catalyst Pharmaceuticals insiders have been selling company stock? The following insiders have sold CPRX shares in the last 24 months: Alicia Grande ($10,070,866.90), Brian Elsbernd ($803,500.00), Carmen Jeffrey Del ($668,000.00), David S Tierney ($788,100.00), Donald A Denkhaus ($638,600.00), Gary Ingenito ($165,630.90), Patrick J Mcenany ($9,350,605.18), Philip H Coelho ($1,240,582.55), Preethi Sundaram ($1,194,075.54), and Steve Miller ($5,422,767.70). How much insider selling is happening at Catalyst Pharmaceuticals? Insiders have sold a total of 1,994,366 Catalyst Pharmaceuticals shares in the last 24 months for a total of $30,342,728.77 sold. More Insider Trading Tools from MarketBeat Related Companies: Amneal Pharmaceuticals Insider Transactions Rhythm Pharmaceuticals Insider Transactions Agios Pharmaceuticals Insider Transactions Summit Therapeutics Insider Transactions Arvinas Insider Transactions OPKO Health Insider Transactions Xencor Insider Transactions Amylyx Pharmaceuticals Insider Transactions Ironwood Pharmaceuticals Insider Transactions TG Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders and Institutions are Scooping Up SelectQuoteInstitutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying This page (NASDAQ:CPRX) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.